Novartispharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Explore Stories | Novartis
Description Explore stories about how Novartis innovation has impacted people worldwide.
Keywords novartis, novartis stories, global impact
Server Information
WebSite novartispharma favicon www.novartispharma.com
Host IP 45.60.11.232
Location United States
Related Websites
Site Rank
patientassistancenow.com #2,561,323
novartisoncology.com #2,331,984
ciprodex.com #2,121,379
More to Explore
nowteam.net
nucot.co.in
nursingassistantguides.com
nuskin.sharepoint.com
nuxtpro.com
nxtdial.com
oasiswfs.in
objectif-bastille.com
oboronhim.ru
ohayosensei.com
easysexmarket.com
eclipse-print.de
Novartispharma.com Valuation
US$29,844
Last updated: Jan 11, 2020

Novartispharma.com has global traffic rank of 1,716,295. Novartispharma.com has an estimated worth of US$ 29,844, based on its estimated Ads revenue. Novartispharma.com receives approximately 1,817 unique visitors each day. Its web server is located in United States, with IP address 45.60.11.232. According to SiteAdvisor, novartispharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$29,844
Daily Ads Revenue US$16
Monthly Ads Revenue US$490
Yearly Ads Revenue US$5,968
Daily Unique Visitors 1,817
Note: All traffic and earnings values are estimates.
Traffic Ranks
Global Rank 1,716,295
Delta (90 Days) 0
Most Popular In Country N/A
Country Rank N/A
DNS Records
Host Type TTL Data
novartispharma.com A 21599 IP: 45.60.11.232
novartispharma.com A 21599 IP: 45.60.13.232
novartispharma.com NS 21599 Target: dns4.novartis.com.
novartispharma.com NS 21599 Target: dns2.novartis.com.
novartispharma.com NS 21599 Target: dns3.novartis.com.
novartispharma.com NS 21599 Target: dns1.novartis.com.
novartispharma.com TXT 21599 TXT: QuoVadis=8c5c8859-79dc-463e-a1cb-372bd00b49ba
novartispharma.com TXT 21599 TXT: 7cdd5904eb31493b86849e2bf3213f6d
novartispharma.com TXT 21599 TXT: _globalsign-domain-verification=7sds8V_yxJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna
novartispharma.com SOA 21599 MNAME: dns1.novartis.com.
RNAME: hostmaster.novartis.com.
Serial: 2019103002
Refresh: 28800
Retry: 7200
Expire: 604800
Minimum TTL: 3600
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 11 Jan 2020 06:51:17 GMT
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Type: text/html; charset=iso-8859-1
Location: https://www.novartispharmaceuticals.com/
Vary: Accept-Encoding
Content-Length: 248
Set-Cookie: visid_incap_1358217=4nB0daxMQPOOVeY0EWP95WVwGV4AAAAAQUIPAAAAAACRjGuSyGpgzmQ+7XgYJ5XG; expires=Sat, 09 Jan 2021 08:32:51 GMT; path=/; Domain=.novartispharma.com
Set-Cookie: incap_ses_635_1358217=PBjTO3zgmVer54VvX/rPCGVwGV4AAAAAKxh9W/BqaKmBquowM3cKSg==; path=/; Domain=.novartispharma.com
Set-Cookie: ___utmvmpsuPvEwB=eQCzEDXSREY; path=/; Max-Age=900
Set-Cookie: ___utmvapsuPvEwB=ThvFSiO; path=/; Max-Age=900
Set-Cookie: ___utmvbpsuPvEwB=LZa
    XCVOYalE: Ptq; path=/; Max-Age=900
X-CDN: Incapsula
X-Iinfo: 4-339558877-339559121 NNNN CT(272 -1 0) RT(1578725475470 0) q(0 17 20 0) r(23 23) U5

HTTP/2 301 
date: Sat, 11 Jan 2020 06:51:19 GMT
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
content-type: text/html; charset=iso-8859-1
location: https://www.novartis.com/stories
vary: Accept-Encoding
content-length: 240
set-cookie: visid_incap_1358217=j5xV8D7+SjKxG5yAIBkBH2ZwGV4AAAAAQUIPAAAAAACGV1NKBuuoWHG0aH9cmUYz; expires=Sat, 09 Jan 2021 09:26:29 GMT; path=/; Domain=.novartispharmaceuticals.com
set-cookie: incap_ses_895_1358217=CRhMIXkixmG0CsKmqK5rDGdwGV4AAAAAed/OOtjbrh+i+v4oUndEnQ==; path=/; Domain=.novartispharmaceuticals.com
x-cdn: Incapsula
x-iinfo: 14-409409960-409409961 NNNN CT(238 482 0) RT(1578725478103 0) q(0 0 7 0) r(9 9) U5

HTTP/2 200 
date: Sat, 11 Jan 2020 06:51:21 GMT
content-type: text/html; charset=utf-8
set-cookie: __cfduid=dca4dbcf40499905d941655233d2a51d31578725480; expires=Mon, 10-Feb-20 06:51:20 GMT; path=/; domain=.novartis.com; HttpOnly; SameSite=Lax; Secure
x-drupal-cache: MISS
x-content-type-options: nosniff
x-xss-protection: 1; mode=block
x-frame-options: SAMEORIGIN
strict-transport-security: max-age=31536000; includeSubDomains
content-language: en
x-ua-compatible: IE=edge,chrome=1
link: <https://www.novartis.com/stories>; rel="canonical",<https://www.novartis.com/stories>; rel="shortlink"
cache-control: public, max-age=60
last-modified: Sat, 11 Jan 2020 06:51:20 GMT
expires: Sun, 19 Nov 1978 05:00:00 GMT
vary: Cookie,Accept-Encoding
x-request-id: v-c66bd684-343e-11ea-b344-bb4f66fbbae8
x-ah-environment: prod
via: varnish
x-cache: MISS
cf-cache-status: EXPIRED
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 5534f62aca9e946d-NRT

Novartispharma.com Whois Information
   Domain Name: NOVARTISPHARMA.COM
   Registry Domain ID: 11748121_DOMAIN_COM-VRSN
   Registrar WHOIS Server: whois.markmonitor.com
   Registrar URL: http://www.markmonitor.com
   Updated Date: 2019-06-18T20:00:06Z
   Creation Date: 1999-10-27T12:09:24Z
   Registry Expiry Date: 2020-10-27T12:09:24Z
   Registrar: MarkMonitor Inc.
   Registrar IANA ID: 292
   Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
   Registrar Abuse Contact Phone: +1.2083895740
   Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
   Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
   Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
   Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
   Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
   Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
   Name Server: DNS1.NOVARTIS.COM
   Name Server: DNS2.NOVARTIS.COM
   Name Server: DNS3.NOVARTIS.COM
   Name Server: DNS4.NOVARTIS.COM
   DNSSEC: unsigned
   URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/

Domain Name: novartispharma.com
Registry Domain ID: 11748121_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2020-01-10T00:10:01-0800
Creation Date: 1999-10-27T00:00:00-0700
Registrar Registration Expiration Date: 2020-10-27T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895770
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Domain Status: serverUpdateProhibited (https://www.icann.org/epp#serverUpdateProhibited)
Domain Status: serverTransferProhibited (https://www.icann.org/epp#serverTransferProhibited)
Domain Status: serverDeleteProhibited (https://www.icann.org/epp#serverDeleteProhibited)
Registry Registrant ID: 
Registrant Name: Domain Admin
Registrant Organization: Novartis AG
Registrant Street: P.O. Box CH-4002, 
Registrant City: Basel
Registrant State/Province: CH
Registrant Postal Code: 4002
Registrant Country: CH
Registrant Phone: +1.2083895740
Registrant Phone Ext: 
Registrant Fax: +1.2083895799
Registrant Fax Ext: 
Registrant Email: novartis.domains@markmonitor.com
Admin Organization: MarkMonitor, Inc.
Admin State/Province: ID
Admin Country: US
Tech Organization: MarkMonitor, Inc.
Tech State/Province: ID
Tech Country: US
Name Server: dns4.novartis.com
Name Server: dns2.novartis.com
Name Server: dns3.novartis.com
Name Server: dns1.novartis.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/

MarkMonitor is the Global Leader in Online Brand Protection.

MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiCounterfeiting(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services

Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220